Cidara Therapeutics, Inc. - stock earnings
CDTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.2 million USD | 12.7 million USD |
| 2023Q2 | -12.4 million USD | 7.6 million USD |
| 2023Q1 | 2.5 million USD | 26.0 million USD |
| 2022Q4 | -13.4 million USD | 10.2 million USD |
| 2022Q3 | 11.9 million USD | 40.7 million USD |
| 2022Q2 | -13.1 million USD | 6.2 million USD |
| 2022Q1 | -18.3 million USD | 7.1 million USD |
| 2021Q4 | -16.8 million USD | 7.2 million USD |
| 2021Q3 | -18.1 million USD | 7.1 million USD |
| 2021Q2 | 10.7 million USD | 32.9 million USD |
| 2021Q1 | -18.3 million USD | 2.4 million USD |
| 2020Q4 | -21.6 million USD | 3.7 million USD |
| 2020Q3 | -17.6 million USD | 2.4 million USD |
| 2020Q2 | -18.3 million USD | 3.4 million USD |
| 2020Q1 | -14.5 million USD | 2.5 million USD |
| 2019Q4 | -14.0 million USD | 1.8 million USD |
| 2019Q3 | 3.0 million USD | 19.1 million USD |
| 2019Q2 | -13.5 million USD | ? USD |
| 2019Q1 | -16.6 million USD | ? USD |
| 2018Q4 | -12.3 million USD | ? USD |
| 2018Q3 | -13.6 million USD | ? USD |
| 2018Q2 | -16.3 million USD | ? USD |
| 2018Q1 | -16.7 million USD | ? USD |
| 2017Q4 | -13.4 million USD | ? USD |
| 2017Q3 | -12.3 million USD | ? USD |
| 2017Q2 | -16.6 million USD | ? USD |
| 2017Q1 | -13.4 million USD | ? USD |
| 2016Q4 | -14.4 million USD | ? USD |
| 2016Q3 | -12.2 million USD | ? USD |
| 2016Q2 | -11.8 million USD | ? USD |
| 2016Q1 | -9.8 million USD | ? USD |
| 2015Q4 | -9.9 million USD | ? USD |
| 2015Q3 | -9.2 million USD | ? USD |
| 2015Q2 | -6.4 million USD | ? USD |
| 2015Q1 | -6.7 million USD | ? USD |
| 2014Q4 | -4.6 million USD | ? USD |
| 2014Q3 | -3.3 million USD | ? USD |
| 2014Q2 | -3.2 million USD | ? USD |
| 2014Q1 | -707000 USD | ? USD |
CDTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.7 million USD | 56.5 million USD |
| 2022 | -29.8 million USD | 64.3 million USD |
| 2021 | -43.9 million USD | 49.6 million USD |
| 2020 | -72.4 million USD | 12.1 million USD |
| 2019 | -40.1 million USD | 20.9 million USD |
| 2018 | -59.0 million USD | ? USD |
| 2017 | -55.7 million USD | ? USD |
| 2016 | -48.2 million USD | ? USD |
| 2015 | -32.2 million USD | ? USD |
| 2014 | -11.9 million USD | ? USD |
| 2013 | -1.3 million USD | ? USD |
CDTX
Price: $12.51
52 week price:
Earnings Per Share: -0.39 USD
P/E Ratio: -1.87
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3.0 million
Ebitda: -12.1 millionMarket Capitalization: 66.2 million